AbbVie Inc (ABBV)

ABBV (NYSE:Drugs)
$54.41
pos +1.04
+1.95%
Today's Range: 52.25 - 54.59 | ABBV Avg Daily Volume: 13,965,800
Last Update: 10/20/14 - 4:00 PM EDT
Volume: 17,912,457
YTD Performance: 1.06%
Open: $52.55
Previous Close: $53.37
52 Week Range: $45.50 - $60.02
Oustanding Shares: 1,591,699,124
Market Cap: 84,200,883,660
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 5 4
Moderate Buy 0 0 0 0
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.57 1.57 1.57 1.86
Latest Dividend: 0.42
Latest Dividend Yield: 2.90%
Dividend Ex-Date: 07/11/14
Price Earnings Ratio: 22.45
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
22.45 11.50 26.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.28% 10.80% 0.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue 5.40 0.00 0.00
Net Income 53.70 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for ABBV:
EBITDA 6.97B
Revenue 18.38B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.77 $0.88 $3.16 $3.97
Number of Analysts 3 2 7 7
High Estimate $0.78 $0.92 $3.23 $4.30
Low Estimate $0.77 $0.83 $3.10 $3.70
Prior Year $0.82 $0.82 $3.14 $3.16
Growth Rate (Year over Year) -5.69% 6.71% 0.59% 25.55%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
We now have an investable bottom on our hands.
It's unlikely that they will be hit by Europe or the Ebola scare. 
There will likely be more selling until the elusive bottom is reached.

This Morning's Market Setup Real Money Pro($)

 Where it began.
The two tech giants help women freeze their eggs.
We are buying the weakness, albeit slowly.
Update
Jul 28, 2014 | 8:03 AM EDT
ABBV was upgraded to Buy from Neutral, UBS said. Reflective of accretive Shire deal. $67 price target. 
Bullish
Jul 23, 2014 | 7:41 AM EDT
ABBV was placed on the US 1 list, according to Bank of America/Merrill Lynch said. Estimates also increased, given higher expected Hepa...

This Morning's Market Setup Real Money Pro($)

Where it began.
Bullish
May 07, 2014 | 8:12 AM EDT
ABBV was upgraded from Equal-weight to Overweight, Morgan Stanley said. $60 price target. Company has an attractive pipeline and can ge...

Columnist Conversations

At the bottom last Wednesday I doubt that many people would have predicted the headline above. I certainly wo...
FB has earnings due out on 10-28-2014, after the market closes. I will write a full earnings preview for Mark...
Solid opening day to trading week for a change as indices across the board as even the DJIA manages to end up ...
Apple reports after the close today. St expecting Q4 rev of $39.877 billion, up 6.4%. EPS of $1.31. FY14 rev o...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.